title: Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials.
authors: Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors: Jose A
authors: JA
authors: Karam
authors: Christopher G
authors: CG
authors: Wood